ENTITY
Hyphens Pharma International

Hyphens Pharma International (HYP SP)

29
Analysis
Health CareSingapore
Hyphens Pharma International Limited is Singapore’s leading specialty pharmaceutical and consumer healthcare group. It develops and owns several dermatological products and supplements, such as Ceradan, TDF and Ocean Health. The Group also markets and sells specialty pharmaceutical products through exclusive agreements, as well as operates an online B2B platform for healthcare professionals. Please visit us at https://www.hyphensgroup.com for more information.
more
Refresh
19 Nov 2020 08:00Exchange-sponsored

(Non-SGX Report) Hyphens Pharma International Limited: Q3 Set-Back, Longer-Term Growth Is Priority

Non- SGX Report: These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external...

Share
16 Nov 2020 08:00Exchange-sponsored

(Non-SGX Report)  Hyphens Pharma Intl Ltd: Short Term Speed Bump in the Pursuit of Growth

Non- SGX Report: These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external...

Share
06 Nov 2020 08:00Exchange-sponsored

(Non-SGX Report) Hyphens Pharma Intl Ltd: Skin Is the Game

Non- SGX Report: These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external...

29 Sep 2020 08:00Exchange-sponsored

Non-SGX Report: Hyphens Pharma International Limited

Non- SGX Report: These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external...

Share
31 Aug 2020 08:00Exchange-sponsored

Non-SGX Report: Hyphens Pharma International Limited: Broadening Product Range and Footprints

Non- SGX Report: These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external...

Share
x